PA
AS

Agadia Systems

AI-powered utilization management platform automating prior authorization for 100M+ covered lives across 55+ health plan and PBM customers, with an emerging specialty drug ePA portal for pharma.

Visit Website

Known For

Agadia occupies a distinct niche in the PA technology landscape as a payer-controlled automation platform, contrasting with the delegated UM model used by its primary competitor:

Overview

Agadia Systems is a founder-led, privately held software company providing AI-powered utilization management (UM) solutions for health plans, PBMs, and TPAs. Founded in 2007 by Sri Swarna (CEO and President), the company has grown to serve 55+ health plan/PBM customers covering over 100 million lives, processing 13 million+ prior authorization requests annually. Headquartered in Parsippany, NJ with a planned relocation to a newly purchased Morris Plains, NJ facility in early 2026, Agadia has operated for 18 years at scale without disclosed venture capital — suggesting strong unit economics and a disciplined, profitable growth model.

The company’s core business is payer-side PA automation, but its 2025 launch of PromptPA marks a meaningful pivot toward the pharma/specialty pharmacy market as a secondary customer segment.

Services & Capabilities

Core Platform: PAHub

End-to-end prior authorization platform for payers and PBMs, supporting both medical and pharmacy benefits across multiple intake channels:

  • Electronic PA (ePA): Real-time electronic submissions via NCPDP SCRIPT, EMR integrations
  • Fax PA: Automated fax intake with OCR/NLP processing
  • Phone PA: Call center workflow management
  • EMR Integration: Direct provider-system connectivity
  • Unified Medical + Pharmacy: Single platform for both benefit types, eliminating the dual-system problem most payers face

AI/ML Modules

  • CriteriaBuilder: Converts written clinical policies into executable decision logic, reducing manual criteria coding
  • ClinIntel: NLP and OCR engine that extracts clinical information from unstructured documents (fax, attachments, clinical notes)
  • Auto-Decisioning: Rules-based + ML-driven automated PA adjudication for routine requests
  • PAHub Insights: Power BI-based analytics and reporting dashboard

PromptPA (Launched February 2025)

Specialty drug ePA portal designed for hub services, specialty pharmacies, and drug manufacturers. Key stats:

  • Connected to 45+ health plans at launch
  • 92 million covered lives accessible
  • Enables pharma-side PA submission and tracking for specialty drugs
  • Represents Agadia’s bridge from payer infrastructure into the pharma services ecosystem

Adjacent Products

  • RxMTM+: Medication therapy management platform for Part D compliance
  • RxSentinel+: Part D Star Ratings adherence monitoring and intervention
  • FormularyHub: Formulary benefit design and management
  • GrievancesHub: Grievances and appeals management (launched 2024)

CMS-0057-F Compliance

Agadia has built out full CMS Interoperability Rule compliance with live APIs:

  • Patient Access API
  • Provider Access API
  • Payer-to-Payer API
  • Prior Authorization API
  • March 2026 readiness confirmed via company blog post

Competitive Position

Agadia occupies a distinct niche in the PA technology landscape as a payer-controlled automation platform, contrasting with the delegated UM model used by its primary competitor:

DimensionAgadia SystemsCohere Health
ModelPayer-controlled PA (tools for plan’s own staff)Delegated UM (Cohere makes decisions on plan’s behalf)
FundingBootstrapped/private$200M+ venture-backed
Scale55+ plans, 100M+ lives, 13M+ PAs/year660K+ providers, 12M+ PAs/year
AI ApproachCriteriaBuilder + ClinIntel (augment payer staff)End-to-end AI decisioning (replace payer staff)
Pharma PlayPromptPA (ePA portal)None currently

Other competitors include legacy payer UM modules within claims platforms (e.g., built-in tools from Cotiviti, Change Healthcare) and point solutions for ePA on the provider side (CoverMyMeds/McKesson, Surescripts).

Differentiation: Unified medical + pharmacy PA in a single platform; payer-controlled model preserves plan autonomy; 18-year track record without VC dilution signals sustainable economics; PromptPA creates a unique pharma-facing channel built atop payer infrastructure.

Recent Developments

  • February 2025: Launched PromptPA specialty drug ePA portal with 45+ health plans and 92M covered lives at launch
  • September 2025: Purchased $10.25M building in Morris Plains, NJ for new headquarters, signaling financial health and growth confidence
  • 2024: Launched GrievancesHub for grievances and appeals management
  • March 2026: Published CMS-0057-F readiness confirmation with all four required APIs live
  • Seed Investment: Made a seed investment in Haystack Robotics, indicating diversification interest

Client & Partner Ecosystem

  • Payer Clients: 55+ health plans and PBMs (names largely undisclosed); MedOne is a named client. Mix of national PBMs and regional health plans with long-term retention.
  • PromptPA Clients: Hub services companies, specialty pharmacies, drug manufacturers (emerging segment)
  • Technology: Power BI partnership for analytics; NCPDP SCRIPT and FHIR standards for interoperability

Cross-References

Technology Platform

  • PAHub: Core SaaS platform for payer UM operations
  • PromptPA: Separate portal for pharma/SP-side PA submission
  • RxMTM+, RxSentinel+, FormularyHub, GrievancesHub: Adjacent SaaS modules
  • HITRUST Certified: Security/compliance certification
  • Power BI: Embedded analytics layer
  • FHIR/NCPDP SCRIPT: Standards-based interoperability

Sources